300
Participants
Start Date
November 11, 2024
Primary Completion Date
December 21, 2024
Study Completion Date
February 25, 2025
Dihydroartemisin-piperaquine
All children with S. mansoni and/or S. haematobium infections at enrolment will then be treated with dihydroartemisinin-piperaquine (DP) and followed up on days 1, 2, 3, 4, 28, and 42 to assess the efficacy and safety of DP.
Banfora, Banfora
Institut de Recherche en Sciences de la Sante, Burkina Faso
OTHER_GOV
University of Ghana
OTHER
Centre MURAZ/Institut National de Santé Publique
OTHER_GOV